Earnings · China A-shares

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A (300255) earnings

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit +15.45% year on year, +10.66% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +0.68% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-29
Period end
2026-09-30
Net profit YoY
+15.45%
Excl. one-offs YoY
+10.66%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+0.10%—
3 days+0.68%—
7 days+2.73%—
14 days-9.65%—

Report history

Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 6 of 6 reports (average +10.18%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-30-¥37.89M+15.45%+10.66%+8.10%-0.04-3.20%+0.68%——
2026 interim report2026-08-26-¥16.76M+42.38%+27.75%-3.21%-0.02-1.40%+1.29%-13.33%-6.33%
2026 Q1 report2026-04-29¥5.87M+55.21%-57.75%-1.00%0.010.49%+17.42%-9.86%-10.81%
2025 annual report2026-04-29-¥357.90M-43.46%-24.66%-15.10%-0.39-25.87%+17.42%-9.86%-10.81%
2025 Q3 report2025-10-30-¥44.82M-714.77%-69.41%-13.11%-0.05-2.91%+19.28%+14.47%+19.22%
2025 interim report2025-08-23-¥29.09M+37.98%+43.62%-13.42%-0.03-1.88%+7.82%+2.69%-2.18%
2025 Q1 report2025-04-29¥3.78M+106.13%+104.86%-12.10%0.000.24%+14.56%+147.08%+144.50%
2024 annual report2025-04-29-¥249.48M+79.88%+77.24%-26.92%-0.27-14.79%+14.56%+147.08%+144.50%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 300255

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.